The 2000% was for a bladder pain drug. What do you think the run up will be if they view this a non-chemo, effective treatment for GBM and then also start looking at the potential of direct for all inoperable solid tumor cancers. If we can get L approved and NWBO starts bring in some revenue all of this can turn around in a heartbeat. $3 will in no way be the ceiling. It will just be the start . . . but you are also right that their are forces at work that are driving he price as low as possible befor the phase-3 results are announced to try to prevent any of this from happening or trying to position the company for a take over. There is no way they want Linda to reap the rewards from all her dogged determination and hard work.